ACUT — ACCUSTEM SCIENCES Balance Sheet
0.000.00%
- $17.52m
- $17.48m
- 17
- 35
- 64
- 32
Annual balance sheet for ACCUSTEM SCIENCES, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | — | — | 0.734 | 0.021 | 0.005 |
Net Total Receivables | 1.37 | 1.35 | 0 | — | — |
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 1.37 | 1.35 | 0.932 | 0.13 | 0.05 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | — | — | 0.008 | 0.004 | 0 |
Total Assets | 1.37 | 1.35 | 0.94 | 0.134 | 0.051 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 0.055 | 0.703 | 1.08 | 2.25 | 3.36 |
Total Long Term Debt | |||||
Total Debt | |||||
Total Liabilities | 0.055 | 0.703 | 1.08 | 2.25 | 3.36 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 1.31 | 0.651 | -0.14 | -2.11 | -3.31 |
Total Liabilities & Shareholders' Equity | 1.37 | 1.35 | 0.94 | 0.134 | 0.051 |
Total Common Shares Outstanding |